Atad3a-flox Mouse
Common Name
Atad3a-flox
제품 ID
S-CKO-17584
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-108888-Atad3a-B6J-VC
상태
이 마우스 계통을 논문에서 사용할 경우, “Atad3a-flox Mouse (카탈로그 번호 S-CKO-17584)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Atad3a-flox
품종 계통계통 ID
CKOCMP-108888-Atad3a-B6J-VC
유전자명
제품 ID
S-CKO-17584
유전자 별칭
Tob3, Atad3, mKIAA1273, 2400004H09Rik
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 4
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000030903
NCBI 전사체 ID
NM_179203.3
타겟 영역
Exon 2~4
유효 영역 크기
~2.3 kb
유전자 연구 개요
Atad3a, an ATPase family AAA-domain containing protein 3A, is a nuclear-encoded mitochondrial membrane protein [3,6]. It is a member of the AAA-domain-containing ATPases superfamily and is crucial for maintaining mitochondrial DNA, structure, and function. Atad3a is involved in diverse cellular processes such as mitochondrial dynamics, cell death, cholesterol metabolism, and protein translation [3,6]. It also plays a role in the mitochondria-endoplasmic reticulum connection and is associated with multiple pathways including mitophagy, cholesterol mitochondrial trafficking, and the regulation of interferon signaling [1,2,3,5].
In Drosophila, overexpression of borR534W, homologous to the human c.1582C>T (p.Arg528Trp) variant in Atad3a, led to decreased mitochondrial content, abnormal morphology, and increased autophagy, while homozygous null bor larvae showed a significant decrease in mitochondria, and overexpression of borWT resulted in larger, elongated mitochondria [6]. In 5XFAD mouse models of Alzheimer's disease, ATAD3A oligomerization at the mitochondria-associated ER membranes led to cholesterol accumulation, APP processing, and synaptic loss, and suppressing ATAD3A oligomerization restored normal brain cholesterol turnover and reduced neuropathology and cognitive deficits [4]. In triple-negative breast cancer, paclitaxel increased ATAD3A expression, disrupting PD-L1 proteostasis by restraining PINK1-dependent mitophagy, and targeting ATAD3A could reset the antitumor immune microenvironment and increase the efficacy of chemoimmunotherapy [2].
In conclusion, Atad3a is essential for mitochondrial function and dynamics. Studies using genetic models like Drosophila and mouse models have revealed its role in various disease conditions such as neurological syndromes, Alzheimer's disease, and breast cancer. These models have provided insights into how Atad3a mutations or dysregulation can lead to disruptions in cellular processes, highlighting its potential as a therapeutic target in these diseases.
References:
1. Chen, Liting, Li, Yuchang, Zambidis, Alexander, Papadopoulos, Vassilios. 2023. ATAD3A: A Key Regulator of Mitochondria-Associated Diseases. In International journal of molecular sciences, 24, . doi:10.3390/ijms241512511. https://pubmed.ncbi.nlm.nih.gov/37569886/
2. Xie, Xiao-Qing, Yang, Yi, Wang, Qiang, Jin, Guoxiang, Bian, Xiu-Wu. 2023. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. In Cell research, 33, 215-228. doi:10.1038/s41422-022-00766-z. https://pubmed.ncbi.nlm.nih.gov/36627348/
3. Teng, Yong, Lang, Liwei, Shay, Chloe. . ATAD3A on the Path to Cancer. In Advances in experimental medicine and biology, 1134, 259-269. doi:10.1007/978-3-030-12668-1_14. https://pubmed.ncbi.nlm.nih.gov/30919342/
4. Zhao, Yuanyuan, Hu, Di, Wang, Rihua, Xu, Rong, Qi, Xin. 2022. ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer's disease models. In Nature communications, 13, 1121. doi:10.1038/s41467-022-28769-9. https://pubmed.ncbi.nlm.nih.gov/35236834/
5. Lepelley, Alice, Della Mina, Erika, Van Nieuwenhove, Erika, Bader-Meunier, Brigitte, Crow, Yanick J. 2021. Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A. In The Journal of experimental medicine, 218, . doi:10.1084/jem.20201560. https://pubmed.ncbi.nlm.nih.gov/34387651/
6. Harel, Tamar, Yoon, Wan Hee, Garone, Caterina, Bellen, Hugo J, Lupski, James R. 2016. Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes. In American journal of human genetics, 99, 831-845. doi:10.1016/j.ajhg.2016.08.007. https://pubmed.ncbi.nlm.nih.gov/27640307/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
